StockData
ProMIS Neurosciences Inc. logo

ProMIS Neurosciences Inc. (PMN) income statement

PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$3.16−0.05 (-1.56%)

Close on Nov 20, 2026Market cap $28.34MP/E –Yield –

See a number that looks wrong?